FIG. 4.

Implantation of the UBM scaffold reduced motor deficits in the controlled cortical impact (CCI) model of TBI. Injection of the UBM scaffold (5 μL) was performed at 24 h after CCI, and motor functions were evaluated 1–5 days after CCI. The graphs illustrate the quantitative analysis of the beam balance performance (A), beam walking performance (B), and beam balance score (C) among the 3 groups of rats. Data are mean±SD, *p<0.05 between TBI+vehicle and TBI+UBM groups. Color images available online at www.liebertpub.com/tea